Motorola Inc. joined the bandwagon of launching touch-screen phones with its new addition in the category named the Krave ZN4. The latest phone boasts of an interactive clear flip screen, 3G connectivity, Bluetooth, and state-of-the-art multimedia functions. Experts say that the phone is a consumer’s delight, with access to web-based email, an HTML browser, and a MicroSD slot for memory cards expandable up to 8GB. The phone also allows users to upload picture photos over the air to different websites and reception facility of voice-dialed calls without opening the cover. Many analysts comment that the phone is reasonably priced at $149.99 after a $50 mail-in rebate with a new two-year contract agreement. Verizon wireless subscribers seeking a touch-screen phone now have a great option with Krave ZN4, experts note.
Apple Introduces New MacBooks at Old Prices
The new versions of Apple MacBook and MacBook Air have been launched by Apple Inc. with minimal changes in the old rates. Both the MacBooks now come with the Nvidia GeForce 9400M graphics chip, which Apple CEO Steve Jobs said delivers ''five times the graphics performance'' compared to Intel X3100 graphics which were used in the older versions. The company has trimmed the price of the new basic MacBook by $100, to a revised rate of $999. A new midlevel MacBook has also been introduced with many of the features of the MacBook Pro, prices starting at $1,300, the same as its midrange predecessor. A version of the swankier MacBook Pro can be bought for $2,000, again, the same price as that of its antecedent. Many IT experts have opined that one should opt for the newer version of MacBook which is half a pound lighter, much faster, and relatively cheaper than its old model.
Pfizer Agrees to Cough Out $894 Million to Resolve Painkiller Drug Lawsuits
Pfizer, the world’s biggest drug maker, has agreed to shell out $894 million to resolve and quell an astounding number of 8,000 lawsuits involving its painkiller drugs. The drugs, Celebrex and Bextra, which have been a dominant source of income for Pfizer, were alleged to cause heart attacks and strokes. The tentative agreement resolves more than 90% of the lawsuits, including those filed by attorney generals in 33 states and the District of Columbia. In a statement to the press, Pfizer’s general counsel, Amy Schulman said that, under the agreement, Pfizer will also pay $60 million to 33 states and Washington, DC, over alleged illegal promotion of Bextra and $89 million for consumer fraud lawsuits. Meanwhile, Connecticut Attorney General Richard Blumenthal has disagreed with filing of any settlement or any approval rendered by the court. He also commented that Pfizer’s announcement was ''premature and inappropriate.''
